Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06303752
PHASE1/PHASE2

Tissue Therapy of Transsphincteric Anal Fistula

Sponsor: University of Southern Denmark

View on ClinicalTrials.gov

Summary

This clinical study aims to evaluate the outcome of the treatment of complex perianal fistulas (PAF) by the combination of minimal surgical debridement with regenerative cellular therapeutics.

Official title: Repairing Peri-Anal Fistulas With Regenerative Cell Therapeutics

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

75

Start Date

2024-10-09

Completion Date

2028-10-08

Last Updated

2024-11-05

Healthy Volunteers

No

Conditions

Interventions

DRUG

ADRC injection

Allocated patients will receive injection of 5 ml suspension including 30 million autologous adipose-derived regenerative cells ADRC and injected at the same site of the lipoaspirate injection.

DRUG

ADRC001 injection

Allocated patients will receive injection of 5 ml suspension including 30 million allogenic adipose-derived regenerative cells ADRC001 and injected at the same site of the lipoaspirate injection.

Locations (1)

Odense University Hospital

Odense, Denmark